邱 仲峯

Medicine & Life Sciences

1. Radiotherapy 100%
2. Neoplasms 71%
3. Hepatocellular Carcinoma 64%
4. Radiation 36%
5. Neoplasm Metastasis 36%
6. Radiosurgery 36%
7. Circulating Neoplastic Cells 33%
8. Therapeutics 32%
9. Neoplastic Stem Cells 28%
10. Sorafenib 26%
11. Magnetic Resonance Spectroscopy 25%
12. Survival 23%
13. Anthraquinones 23%
14. Head and Neck Neoplasms 22%
15. Cellular Apoptosis Susceptibility Protein 22%
16. Breast Neoplasms 22%
17. Drug Therapy 22%
18. Non-Small Cell Lung Carcinoma 21%
19. Liver 20%
20. Carcinoma 20%
21. Glioma 20%
22. Immunotherapy 20%
23. Respiration 19%
24. Molecular Imaging 19%
25. Hep G2 Cells 18%
26. Antrodia 18%
27. pterostilbene 18%
28. Luminescence 18%
29. Pain 18%
30. Palliative Care 17%
31. Cisplatin 17%
32. Lipid Peroxidation 17%
33. Bone and Bones 17%
34. Pharmaceutical Preparations 17%
35. Liver Neoplasms 17%
36. Chemoradiotherapy 16%
37. Blueberry Plants 16%
38. Rectal Neoplasms 16%
39. Breast 16%
40. Apoptosis 16%
41. SPAD 16%
42. Cultured Tumor Cells 15%
43. Oxidative Stress 15%
44. Nursing 15%
45. Annexins 14%
46. ErbB Receptors 14%
47. Mitoxantrone 14%
48. Cancer Pain 14%
49. Stem Cells 13%
50. Hypoxia-Inducible Factor 1 13%